The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea
Open accessAbstract
Purpose: To further clarify the relationship between total cholesterol and cancer, which remains unclear. Methods: We prospectively examined the association between total cholesterol and site-specific and all-cancer incidence among 1,189,719 Korean adults enrolled in the National Health Insurance Corporation who underwent a standardized biennial medical examination in 1992 to 1995 and were observed for 14 years until cancer diagnosis or death. Results: Over follow-up, 53,944 men and 24,475 women were diagnosed with a primary cancer. Compared with levels less than 160 mg/dL, high total cholesterol (≥ 240 mg/dL) was positively associated with prostate cancer (hazard ratio [HR], 1.24; 95% CI, 1.07 to 1.44; P trend = .001) and colon cancer (HR, 1.12; 95% CI, 1.00 to 1.25; P trend = .05) in men and breast cancer in women (HR, 1.17; 95% CI, 1.03 to 1.33; P trend = .03). Higher total cholesterol was associated with a lower incidence of liver cancer (men: HR, 0.42; 95% CI, 0.38 to 0.45; P trend < .001; women: HR, 0.32; 95% CI, 0.27 to 0.39; P trend < .001), stomach cancer (men: HR, 0.87; 95% CI, 0.82 to 0.93; P trend ≤ .001; women: HR, 0.86; 95% CI, 0.77 to 0.97; P trend = .06), and, in men, lung cancer (HR, 0.89; 95% CI, 0.82 to 0.96; P trend < .001). Results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis B surface antigen status (men: HR, 0.60; P trend < .001; women: HR, 0.46; P trend = .003) and exclusion of the first 10 years of follow-up (men: HR, 0.59; P trend < .001; women: HR, 0.44; P trend < .001). Total cholesterol was inversely associated with all-cancer incidence in both men (HR, 0.84; 95% CI, 0.81 to 0.86; P trend < .001) and women (HR, 0.91; 95% CI, 0.87 to 0.95; P trend < .001), but these associations were attenuated after excluding incident liver cancers (men: HR, 0.95; P trend < .001; women: HR, 0.98; P trend = .32). Conclusion: In this large prospective study, we found that total cholesterol was associated with the risk of several different cancers, although these relationships differed markedly by cancer site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002
Carroll, M. D. (2005) · JAMA · doi:10.1001/jama.294.14.1773 · Cited by 531
Serum Lipid and Lipoprotein Patterns in Patients With Liver Cirrhosis and Chronic Active Hepatitis
Cicognani, C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.7.792 · Cited by 233
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
Ahn, J., Lim, U., Weinstein, S. J., Schatzkin, A., Hayes, R. B., Virtamo, J., & Albanes, D. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1248 · Cited by 207
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
Crawford, E. D. (2009) · Urology · doi:10.1016/j.urology.2009.03.001 · Cited by 174
Schatzkin, A. G., Hoover, R. N., Taylor, P. R., Ziegler, R. G., Carter, C. L., Albanes, D., Larson, D. B., & Licitra, L. (1988) · PubMed · Cited by 153
Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts
Iso, H., Ikeda, A., Inoue, M., Sato, S., & Tsugane, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24668 · Cited by 150
Serum Cholesterol and Cancer Risk: An Epidemiologic Persepective
Kritchevsky, S. B., & Kritchevsky, D. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.002135 · Cited by 146
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
Eliassen, A. H., & Hankinson, S. E. (2008) · PubMed · Cited by 141
Association between plasma cholesterol and prostate cancer in the PSA era
Platz, E. A., Clinton, S. K., & Giovannucci, E. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23715 · Cited by 140
Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
Eliassen, A. H., Colditz, G. A., ROSNER, B. A., Willett, W. C., & Hankinson, S. E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.19.2264 · Cited by 125
Endogenous Hormone Levels and Risk of Breast, Endometrial and Ovarian Cancers:
Eliasen, A., & Hankinson, S. E. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_10 · Cited by 125
Rising prostate cancer rates in South Korea
Park, S. K., Sakoda, L. C., Kang, D., Chokkalingam, A. P., Lee, E., Shin, H., Ahn, Y., Shin, M., Lee, C.-W., Lee, D., et al. (2006) · The Prostate · doi:10.1002/pros.20419 · Cited by 116
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women
Knekt, P., Reunanen, A., Aromaa, A., Heliövaara, M., Hakulinen, T., & Hakama, M. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90056-x · Cited by 115
Heart Protection Study Collaborative Group (2005) · BMC Medicine · doi:10.1186/1741-7015-3-6 · Cited by 114
Risks of Cancer of the Colon and Rectum in Relation to Serum Cholesterol and Beta-Lipoprotein
Törnberg, S., Holm, L., Carstensen, J. M., & EKLUND, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152601 · Cited by 106
Mondul, A. M., Clipp, S. L., Helzlsouer, K. J., & Platz, E. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9434-8 · Cited by 105
Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer.
Kritchevsky, S. B., Wilcosky, T. C., Morris, D. L., Truong, K. N., & Tyroler, H. A. (1991) · PubMed · Cited by 101
Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women
Høyer, A. P., & Engholm, G. (1992) · Cancer Causes & Control · doi:10.1007/bf00051352 · Cited by 96
Statin use, hyperlipidaemia, and the risk of breast cancer
Kaye, J. A., Meier, C. R., Walker, A. M., & Jick, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600267 · Cited by 95
Strasak, A. M., Pfeiffer, R. M., Brant, L. J., Rapp, K., Hilbe, W., Oberaigner, W., Lang, S., Borena, W., Concin, H., Diem, G., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn736 · Cited by 91
EFFECT OF SIMVASTATIN ON GLIOMA CELL PROLIFERATION, MIGRATION, AND APOPTOSIS
Wu, H., Jiang, H., Lu, D., Xiong, Y., Qu, C., Zhou, D., Mahmood, A., & Chopp, M. (2009) · Neurosurgery · doi:10.1227/01.neu.0000360130.52812.1d · Cited by 85
The Vitamin D and Cancer Conundrum: Aiming at a Moving Target
Toner, C. D., Davis, C. D., & Milner, J. A. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.07.007 · Cited by 82
Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women
Gaard, M., Tretli, S., & Urdal, P. (1994) · Cancer Causes & Control · doi:10.1007/bf01831377 · Cited by 82
Asano, K., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., Arima, H., Shirota, T., Matsumoto, T., Iida, M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23191 · Cited by 73
Huxley, R., Lewington, S., & Clarke, R. (2002) · Seminars in Vascular Medicine · doi:10.1055/s-2002-35402 · Cited by 69
Self-citationde González, A. B., Yun, J. E., Lee, S., Klein, A. P., & Jee, S. H. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0507 · Cited by 57
Self-citationA Clinical Review of Statins and Cancer: Helpful or Harmful?
Gonyeau, M. J., & Yuen, D. W. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.2.177 · Cited by 33
Risk of Stomach Cancer in Association with Serum Cholesterol and Beta-Lipoprotein
Tournberg, S. A., Carstensen, J. M., & Holm, L. E. (1988) · Acta Oncologica · doi:10.3109/02841868809090316 · Cited by 25
Cited by
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 839
Seong, S. C., Kim, Y.-Y., Park, S. K., Khang, Y. H., Kim, H. C., Park, J. H., Kang, H.-J., Do, C.-H., Song, J.-S., Lee, E.-J., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016640 · Cited by 830
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Metadata
- Authors
- Kitahara, C. M., Berrington de González, A., Freedman, N. D., Huxley, R., Mok, Y., Jee, S. H., & Samet, J. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-04-20
- Volume
- 29
- Issue
- 12
- Pages
- 1592-1598
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2138331892
- Cited by
- 408
- References
- 29
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.